JPMorgan Chase · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
JPMorgan Chase Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 8.1M | $2.6B | — |
| 2024Q2 | 8.6M | $3.2B | +22.6% |
| 2024Q3 | 8.7M | $3.3B | +4.0% |
| 2024Q4 | 40.8M | $14.0B | +325.2% |
| 2025Q1 | 9.4M | $3.8B | -72.7% |
| 2025Q2 | 10.4M | $2.7B | -30.0% |
| 2025Q3 | 22.3M | $5.1B | +92.1% |
| 2025Q4 | 13.8M | $2.8B | -45.9% |
| 2026Q1 | 16.1M | $3.2B | +13.8% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F